Colgate-Palmolive Company (CL)
Glenmede Investment Management LP Has $38.42 Million Holdings in Colgate-Palmolive Company $CL
Glenmede Investment Management LP grew its position in Colgate-Palmolive Company (NYSE: CL) by 17.6% during the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 480,609 shares of the company's stock after purchasing an additional 71,762 shares during the quarter. Glenmede Investment Management
FORA Capital LLC Has $4.77 Million Stock Holdings in Colgate-Palmolive Company $CL
FORA Capital LLC boosted its position in Colgate-Palmolive Company (NYSE: CL) by 161.2% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 59,696 shares of the company's stock after buying an additional 36,844 shares during the period. Colgate-Palmolive makes up approximately
Arrowstreet Capital Limited Partnership Has $428.40 Million Stake in Colgate-Palmolive Company $CL
Arrowstreet Capital Limited Partnership reduced its stake in Colgate-Palmolive Company (NYSE: CL) by 18.1% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 5,358,971 shares of the company's stock after selling 1,185,137 shares during the period. Arrowstreet Capital Limited
Innovation as Growth Engine: How Colgate Plans to Revive Demand
CL bets on science-led innovation, Colgate Total relaunch and AI-driven marketing to revive demand and boost premium growth across oral care and pet nutrition.
Why Colgate-Palmolive (CL) is a Top Growth Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
5 US Blue Chip Giants That Have Paid Dividends for Over 100 Years
Investors love dividend stocks because they provide dependable passive income streams and an excellent opportunity for solid total return.
Procter & Gamble vs. Colgate: Which Consumer Stock Has More Upside?
CL and PG stack up on growth, margins and valuation as estimates, pricing power and category focus shape their outlooks.
Take the Zacks Approach to Beat the Markets: Intellia, Colgate-Palmolive, Getty in Focus
NTLA, CL and GTY are in focus as Zacks highlights strong 12-week gains and post-upgrade rallies across its Focus List and model portfolios.
Is Colgate's Supply-Chain Resilience Providing Competitive Edge?
CL leans on supply-chain resilience after a volatile 2025, delivering record sales and eyeing margin expansion in 2026.
Colgate-Palmolive (CL) is a Top-Ranked Growth Stock: Should You Buy?
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Pricing vs. Volume: Can Colgate Balance Growth in a Soft Market?
CL faces muted demand and cautious consumers as it balances pricing discipline with volume recovery to protect growth in a soft global market.
Colgate-Palmolive Dividend Scorecard: How Does the 2.6% Yield Stack Up?
Colgate-Palmolive just sent $0.52 per share to investors that will land on February 13, 2026, marking another quarterly payment in the consumer goods giant's 63-year dividend increase streak.
